Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01663285
What this trial is testing

Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)

Who this might be right for
Urothelial CancerBladder Cancer
University of Michigan Rogel Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00645593
What this trial is testing

Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer

Who this might be right for
Bladder Cancer
University of Michigan Rogel Cancer Center 89
Testing effectiveness (Phase 2)Study completedNCT00246974
What this trial is testing

Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT

Who this might be right for
Bladder Cancer
AstraZeneca 125
Testing effectiveness (Phase 2)UnknownNCT04543110
What this trial is testing

Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC

Who this might be right for
Bladder Cancer
Ottawa Hospital Research Institute 16
Testing effectiveness (Phase 2)Study completedNCT03633110
What this trial is testing

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Genocea Biosciences, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT04701918
What this trial is testing

Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial CarcinomaBladder Cancer
Massachusetts General Hospital 9
Testing effectiveness (Phase 2)UnknownNCT01118039
What this trial is testing

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Hospital del Mar 41
Not applicableStudy completedNCT00539773
What this trial is testing

Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

Who this might be right for
Transitional Carcinoma of Urinary Bladder
King Faisal Specialist Hospital & Research Center 10
Not applicableActive Not RecruitingNCT06870253
What this trial is testing

Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases

Who this might be right for
Bladder CancerUrothelial Carcinoma Bladder
Pangea Laboratory LLC 80
Testing effectiveness (Phase 2)Study completedNCT02109328
What this trial is testing

Alisertib in Chemotherapy-pretreated Urothelial Cancer

Who this might be right for
Bladder CancerTransitional Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Testing effectiveness (Phase 2)Study completedNCT04383938
What this trial is testing

Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies

Who this might be right for
Bladder CancerGastric CancerNon Small Cell Lung Cancer+3 more
Aprea Therapeutics 40
Early research (Phase 1)Study completedNCT01162785
What this trial is testing

1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT04045613
What this trial is testing

Derazantinib and Atezolizumab in Patients With Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Basilea Pharmaceutica 95
Testing effectiveness (Phase 2)Study completedNCT00792025
What this trial is testing

Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Institut Curie 80
Not applicableEnded earlyNCT02494635
What this trial is testing

Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer

Who this might be right for
Bladder Papillary Urothelial CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+5 more
University of Southern California 4
Not applicableStudy completedNCT03584659
What this trial is testing

Patient-reported Outcomes in Bladder Cancer

Who this might be right for
Bladder CancerUrothelial Carcinoma
Rigshospitalet, Denmark 230
Very early researchActive Not RecruitingNCT02812420
What this trial is testing

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery

Who this might be right for
HydronephrosisInfiltrating Bladder Urothelial Carcinoma Sarcomatoid VariantInfiltrating Bladder Urothelial Carcinoma, Micropapillary Variant+16 more
M.D. Anderson Cancer Center 54
Large-scale testing (Phase 3)Ended earlyNCT01310803
What this trial is testing

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Who this might be right for
Carcinoma in SituTransitional Cell CarcinomaNon-muscle Invasive Bladder Cancer
Endo USA Inc., a Keenova Therapeutics Company 1
Large-scale testing (Phase 3)Study completedNCT00004154
What this trial is testing

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 111
Not applicableLooking for participantsNCT07756437
What this trial is testing

Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)Upper Tract Urothelial CarcinomaUrothelial Carcinoma (UC)
AZ Sint-Lucas Gent 70
Next Page